Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA) - Mavaddat, N; Barrowdale, D; Andrulis, IL (Cancer Epidemiol Biomarkers Prev, 2012)